PT Kalbe Farma Tbk.
PT Kalbe Farma Tbk. Fundamental Analysis
PT Kalbe Farma Tbk. (PTKFY) shows moderate financial fundamentals with a PE ratio of 14.48, profit margin of 10.16%, and ROE of 15.28%. The company generates $172.1B in annual revenue with moderate year-over-year growth of 7.16%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 74.8/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze PTKFY's fundamental strength across five key dimensions:
Efficiency Score
ExcellentPTKFY demonstrates superior asset utilization.
Valuation Score
ExcellentPTKFY trades at attractive valuation levels.
Growth Score
ExcellentPTKFY delivers strong and consistent growth momentum.
Financial Health Score
ExcellentPTKFY maintains a strong and stable balance sheet.
Profitability Score
ModeratePTKFY maintains healthy but balanced margins.
Key Financial Metrics
Is PTKFY Expensive or Cheap?
P/E Ratio
PTKFY trades at 14.48 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, PTKFY's PEG of 0.00 indicates potential undervaluation.
Price to Book
The market values PT Kalbe Farma Tbk. at 2.22 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 0.73 times EBITDA. This is generally considered low.
How Well Does PTKFY Make Money?
Net Profit Margin
For every $100 in sales, PT Kalbe Farma Tbk. keeps $10.16 as profit after all expenses.
Operating Margin
Core operations generate 12.56 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $15.28 in profit for every $100 of shareholder equity.
ROA
PT Kalbe Farma Tbk. generates $11.68 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
PT Kalbe Farma Tbk. produces operating cash flow of $17.36B, showing steady but balanced cash generation.
Free Cash Flow
PT Kalbe Farma Tbk. produces free cash flow of $13.36B, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $11797.12 in free cash annually.
FCF Yield
PTKFY converts 10.56% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
14.48
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.00
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.22
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.007
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.02
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.85
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.15
vs 25 benchmark
ROA
Return on assets percentage
0.12
vs 25 benchmark
ROCE
Return on capital employed
0.17
vs 25 benchmark
How PTKFY Stacks Against Its Sector Peers
| Metric | PTKFY Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 14.48 | 29.28 | Better (Cheaper) |
| ROE | 15.28% | 820.00% | Weak |
| Net Margin | 10.16% | -19731.00% (disorted) | Strong |
| Debt/Equity | 0.02 | 0.26 | Strong (Low Leverage) |
| Current Ratio | 3.85 | 4.69 | Strong Liquidity |
| ROA | 11.68% | -17993.00% (disorted) | Strong |
PTKFY outperforms its industry in 5 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews PT Kalbe Farma Tbk.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
46.31%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
31.20%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
97.99%
Industry Style: Defensive, Growth, Innovation
High Growth